Glucosamine and method of making glucosamine from microbial biomass
View Patent ↗Glucosamine suitable for human or animal consumption is disclosed. The glucosamine is derived from fungal biomass containing chitin. Various methods of producing glucosamine by acid hydrolysis of fermented fungal biomass are also disclosed.
1. A method of obtaining glucosamine from fungal biomass, the method comprising:
producing a commercial-scale amount of glucosamine suitable for animal and/or human consumption, from fungal biomass through
(a) providing a chitin-containing fungal biomass, which fungal biomass has not been pretreated to release proteins, lipids and/or polysaccharides therein;
(b) reacting the non-pretreated fungal biomass in an acidic solution comprising HCI at a concentration of at least 5%, at a reaction temperature of from about 90° C. to about 160° C. and for a period of time sufficient for said reaction to convert at least about 50% of the chitin in the fungal biomass to glucosamine; and
(c) separating the glucosamine from the acidic solution.
2. The method of claim 1 further comprising forming the glucosamine into a food supplement composition.
3. The method of claim 1 wherein the commercial-scale amount of the glucosamine is produced from the non-pretreated fungal biomass in a single acidic reaction.
4. A method of obtaining glucosamine from fungal biomass comprising:
(a) providing a chitin-containing fungal biomass which fungal biomass has not been pretreated to release proteins, lipids and/or polysaccharides therein;
(b) reacting the non-pretreated fungal biomass in a single acidic reaction in an HCI solution wherein the HCI concentration is at least 5%, at a reaction temperature of from about 90° C. to about 160° C. to convert at least about 50% of the chitin in the fungal biomass to glucosamine during said single acidic reaction step; and
(c) separating the glucosamine from the HCI.
5. The method of claim 4 further comprising forming the glucosamine into a food supplement composition.
6. A method comprising:
producing a food supplement suitable for animal and/or human consumption, from fungal biomass by
providing a chitin-containing fungal biomass which fungal biomass has not been pretreated to release proteins, lipids and/or polysaccharides therein with or without converting a substantial amount of chitin to glucosamine;
reacting the non-pretreated fungal biomass with HCI at a concentration of at least 5%, using only a single acidic reaction, at a reaction temperature of from about 90° C. to about 160° C. to convert at least about 50% of the chitin in the fungal biomass to a commercial-scale amount of the glucosamine during said single acidic reaction;
separating the glucosamine from the HCI; and
forming the glucosamine into a food supplement composition.
7. The method of claim 6 further comprising forming the glucosamine into a food supplement composition on a commercially viable industrial scale.
8. A method of obtaining glucosamine from fungal biomass, the method consisting essentially of:
(a) providing a chitin-containing fungal biomass, which fungal biomass has not been treated to remove proteins, lipids and/or polysaccharides therein;
(b) reacting the fungal biomass in an acidic solution comprising HCI at a concentration of at least at a reaction temperature of from about 90° C. to about 160° C. and for a period sufficient for said reaction to convert at least about 50% of the chitin in the fungal biomass to glucosamine; and
(c) separating the glucosamine from the acidic solution to produce glucosamine suitable for animal and/or human consumption.
9. The method of claim 8 further comprising forming the glucosamine into a food supplement composition on an industrial scale.
10. A composition comprising:
glucosamine derived from whole fungal biomass;
levulinic acid and/or a melanoidin; and
wherein the composition is suitable for human or animal consumption.
11. A composition comprising:
glucosamine derived from non-pretreated fungal biomass;
levulinic acid; and
the composition being suitable for human or animal consumption.
12. The composition of claim 9 wherein the composition comprises from about 0.0001 to about 1 wt. percent levulinic acid.
13. The composition of claim 9 further comprising from about 0.001 to about 1.0 wt. percent melanoidins.
14. A composition comprising:
a food supplement suitable for human or animal consumption including:
a fungal biomass glucosamine;
about 0.0001 to about 1 wt. percent levulinic acid and/or about 0.001 to about 1.0 wt. percent of a melanoidin; and
the complete absence of a muscle protein and shell fish allergens.
15. The composition of claim 14 further comprising 0.0001 to 1 wt. percent levulinic acid.
16. The composition of claim 14 further comprising 0.01 to 1.0 wt. percent melanoidins.
17. A composition comprising:
a nutraceutical including glucosamine derived from non-pretreated fungal biomass and a melanoidin.
18. The composition of claim 17 , wherein the glucosamine composition has an ash content below 2 percent.
19. The composition of claim 17 , wherein the glucosamine composition has a heavy metal content below 20 parts per million.
20. The composition of claim 17 , wherein the glucosamine composition is formed by acid hydrolysis of the fungal biomass.
21. The composition of claim 10 wherein the glucosamine further comprises
a kosher fungal biomass derived glucosamine suitable for human or animal consumption.